{"entity":{"id":"ionpath","kind":"company","name":"Ionpath","aka":["IONpath"],"tldr":"Ionpath made the MIBIscope, an instrument that stains a thin slice of tumour for dozens of proteins at once with metal tags and reads them with an ion beam, so researchers can see which immune and cancer cells sit where. In 2025 the instrument business passed to Oregon Physics.","summary":"Ionpath, of Menlo Park, California, commercialised multiplexed ion beam imaging (MIBI), a technology originally developed at Stanford University in which antibodies tagged with metal isotopes are released from tissue by an ion beam and counted by mass spectrometry, measuring many proteins on one section. The MIBIscope was introduced commercially in 2019. In May 2022 Thermo Fisher Scientific made a strategic investment in the company on undisclosed terms. In 2025 Oregon Physics, which had built the instrument's primary ion source, acquired the MIBIscope platform's intellectual property and commercial rights and took over its manufacture, service and development; ionpath.com now redirects to the MIBIscope website run by Oregon Physics, which names oncology, immunology and tissue atlas studies among its applications.","asOf":"2026-11-03","links":[{"label":"Thermo Fisher strategic investment, May 2022 (press release)","url":"https://www.biospace.com/ionpath-receives-strategic-investment-to-support-spatial-proteomics-innovation"},{"label":"MIBIscope, now run by Oregon Physics","url":"https://mibiscope.com/"},{"label":"MIBIscope history and 2025 transfer","url":"https://mibiscope.com/about/"}],"tags":[],"related":[],"cancers":[],"sections":["diagnostics"],"technologies":["imaging-mass-cytometry","spatial-biology-instruments","single-cell-spatial"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Ionpath's own status after the 2025 transfer could not be confirmed: the MIBIscope website does not mention Ionpath, and no Ionpath announcement of the transfer was read. Stage is left blank for that reason, and no website is recorded. A 2023 Business Wire release reported to describe a shift to a services business returned 403 and was not read. Founding year not verified from a company source. Headquarters is the Menlo Park dateline of the 2022 release. Oregon Physics has no company record in OnCo."],"hq":"Menlo Park, CA","country":"US","companyType":"imaging","investors":[],"funding":[]},"route":"/companies/ionpath/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"}],"technology":[{"id":"imaging-mass-cytometry","kind":"technology","name":"Imaging mass cytometry","route":"/technologies/imaging-mass-cytometry/"},{"id":"single-cell-spatial","kind":"technology","name":"Single-cell & spatial profiling","route":"/technologies/single-cell-spatial/"},{"id":"spatial-biology-instruments","kind":"technology","name":"Spatial biology instruments","route":"/technologies/spatial-biology-instruments/"}]}}